AKT1 and breast cancer: To determine whether Akt mediates IR-induced Bmi-1-regulated migration of breast cancer cells, we analyzed the effect of PI3K inhibitor LY294002 or AKT 1/2 kinase inhibitor AKT I on the migration of the same set of breast cancer cell lines after IR.